Scientist (Immunology), Vienna

Note to candidates: the list below describes a strong profile, not a set of hard requirements. If you do not match every point but believe you are a strong candidate, please apply.

Parallel Bio is redefining human-first drug discovery. Our platform runs high-throughput immune organoid experiments to accelerate the development of new therapeutics. What makes that valuable is not the engineering of the system itself. It is recognising what these models show that simpler systems cannot, and designing experiments whose outputs connect to decisions in drug development. The most common failure in platform biology is invisible: technically sound experiments that never ask a question only this system could answer.